Immunohistochemical studies on the localization of cancer associated antigens DU-PAN-2 and CA19-9 in carcinomas of the digestive tract
- PMID: 2103381
- DOI: 10.1111/j.1440-1746.1990.tb01764.x
Immunohistochemical studies on the localization of cancer associated antigens DU-PAN-2 and CA19-9 in carcinomas of the digestive tract
Abstract
The immunohistochemical localization of DU-PAN-2 antigen and CA19-9 antigen in carcinomas of the digestive tract was studied using an immunoperoxidase technique. Staining for DU-PAN-2 antigen and CA19-9 antigen was observed in 104 (79%) and 96 (73%) of 131 carcinomas of the digestive tract, respectively. Diffuse staining (more than 20% of carcinoma cell stained) for DU-PAN-2 was detected in 14 of 21 (67%) pancreatic carcinomas and 11 of 19 (58%) carcinomas of the biliary tract (including cholangiocarcinoma). Diffuse staining for CA19-9 was detected in 15 (71%) of pancreatic carcinomas and nine (47%) of the carcinomas of the biliary tract. In colon carcinomas, no diffuse staining for DU-PAN-2 was observed, whereas diffuse staining for CA19-9 was found in 41%. There was a positive correlation between the differentiation degree (or grade) of the adenocarcinomas of the colon and the expression of CA19-9, but not that of DU-PAN-2. These immunohistochemical studies showed that DU-PAN-2 antigen is expressed diffusely in most cases of adenocarcinoma of the pancreas and biliary tract and is more specific for adenocarcinomas of the pancreas and biliary tract than CA19-9.
Similar articles
-
Comparative studies of DU-PAN-2, carcinoembryonic antigen, and CA19-9 in the serum and bile of patients with pancreatic and biliary tract diseases: evaluation of the influence of obstructive jaundice.Am J Gastroenterol. 1990 Oct;85(10):1370-6. Am J Gastroenterol. 1990. PMID: 2220731
-
Distribution of the carbohydrate antigens, DU-PAN-2 and CA19-9, in tumors of the lung.Tumori. 1995 Jan-Feb;81(1):67-73. doi: 10.1177/030089169508100116. Tumori. 1995. PMID: 7754546
-
Immunohistochemical localization of CEA, CA19-9 and DU-PAN-2 in hepatitis C virus-infected liver tissues.Histopathology. 2002 May;40(5):472-9. doi: 10.1046/j.1365-2559.2002.01374.x. Histopathology. 2002. PMID: 12010368
-
[Clinical usefulness of tumor markers associated with pancreatic cancer].Rinsho Byori. 1994 Feb;42(2):127-38. Rinsho Byori. 1994. PMID: 7908065 Review. Japanese.
-
The clinical relevance of the tumor marker CA 19-9 in the diagnosing and monitoring of pancreatic carcinoma.Bull Cancer. 1990;77(1):83-91. Bull Cancer. 1990. PMID: 2180502 Review.
Cited by
-
Distribution of Tn antigen recognized by an anti-Tn monoclonal antibody (MLS128) in normal and malignant tissues of the digestive tract.J Cancer Res Clin Oncol. 1995;121(4):247-52. doi: 10.1007/BF01366970. J Cancer Res Clin Oncol. 1995. PMID: 7751324 Free PMC article.
-
Expression of sialosyl-Tn antigen (monoclonal antibody MLS102 reactive) in normal tissues and malignant tumors of the digestive tract.J Cancer Res Clin Oncol. 1994;120(6):325-30. doi: 10.1007/BF01247457. J Cancer Res Clin Oncol. 1994. PMID: 8138557 Free PMC article.
-
CA19-9 as a Potential Target for Radiolabeled Antibody-Based Positron Emission Tomography of Pancreas Cancer.Int J Mol Imaging. 2011;2011:834515. doi: 10.1155/2011/834515. Epub 2011 Sep 6. Int J Mol Imaging. 2011. PMID: 21912743 Free PMC article.
-
Complementary Use of Carbohydrate Antigens Lewis a, Lewis b, and Sialyl-Lewis a (CA19.9 Epitope) in Gastrointestinal Cancers: Biological Rationale Towards A Personalized Clinical Application.Cancers (Basel). 2020 Jun 9;12(6):1509. doi: 10.3390/cancers12061509. Cancers (Basel). 2020. PMID: 32527016 Free PMC article. Review.
-
Selectin Ligands Sialyl-Lewis a and Sialyl-Lewis x in Gastrointestinal Cancers.Biology (Basel). 2017 Feb 23;6(1):16. doi: 10.3390/biology6010016. Biology (Basel). 2017. PMID: 28241499 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources